Norinchukin Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.4M Sell
47,144
-62
-0.1% -$62.9K 0.51% 31
2025
Q4
$50.7M Buy
47,206
+2,817
+6% +$2.69M 0.59% 28
2025
Q3
$33.9M Buy
44,389
+1,582
+4% +$1.18M 0.45% 36
2025
Q2
$33.4M Buy
42,807
+3,865
+10% +$3M 0.5% 35
2025
Q1
$32.2M Buy
38,942
+4,894
+14% +$4.07M 0.59% 33
2024
Q4
$26.3M Buy
34,048
+2,280
+7% +$1.89M 0.56% 37
2024
Q3
$28.1M Buy
31,768
+3,846
+14% +$3.46M 0.66% 31
2024
Q2
$25.3M Buy
27,922
+273
+1% +$218K 0.72% 28
2024
Q1
$21.5M Sell
27,649
-382
-1% -$272K 0.64% 32
2023
Q4
$16.3M Sell
28,031
-2,760
-9% -$1.61M 0.38% 39
2023
Q3
$16.5M Sell
30,791
-34,206
-53% -$17.6M 0.39% 43
2023
Q2
$30.5M Buy
64,997
+19,506
+43% +$8.18M 0.51% 33
2023
Q1
$15.6M Buy
45,491
+1,546
+4% +$521K 0.31% 56
2022
Q4
$16.1M Sell
43,945
-7,166
-14% -$2.54M 0.35% 53
2022
Q3
$16.5M Buy
51,111
+4,039
+9% +$1.28M 0.34% 55
2022
Q2
$15.3M Sell
47,072
-25,301
-35% -$7.59M 0.3% 57
2022
Q1
$20.7M Buy
72,373
+5,353
+8% +$1.38M 0.28% 67
2021
Q4
$18.5M Sell
67,020
-419
-0.6% -$106K 0.23% 74
2021
Q3
$15.6M Buy
67,439
+1,573
+2% +$388K 0.22% 77
2021
Q2
$15.1M Sell
65,866
-303
-0.5% -$60.9K 0.22% 76
2021
Q1
$12.4M Buy
66,169
+1,190
+2% +$233K 0.17% 77
2020
Q4
$11M Sell
64,979
-2,101
-3% -$314K 0.16% 83
2020
Q3
$9.93M Sell
67,080
-3,641
-5% -$564K 0.16% 82
2020
Q2
$11.6M Sell
70,721
-945
-1% -$145K 0.2% 70
2020
Q1
$9.94M Sell
71,666
-65,747
-48% -$9.03M 0.19% 73
2019
Q4
$18.1M Sell
137,413
-10,970
-7% -$1.27M 0.24% 74
2019
Q3
$16.6M Buy
148,383
+771
+0.5% +$85.8K 0.23% 69
2019
Q2
$16.4M Sell
147,612
-60,870
-29% -$7.17M 0.25% 63
2019
Q1
$27.1M Sell
208,482
-12,811
-6% -$1.56M 0.34% 54
2018
Q4
$25.6M Buy
221,293
+49,233
+29% +$5.5M 0.36% 51
2018
Q3
$18.5M Buy
172,060
+14,350
+9% +$1.43M 0.25% 70
2018
Q2
$13.5M Buy
157,710
+17,327
+12% +$1.42M 0.2% 85
2018
Q1
$10.9M Buy
140,383
+11,968
+9% +$963K 0.18% 88
2017
Q4
$10.8M Buy
128,415
+5,294
+4% +$450K 0.19% 85
2017
Q3
$10.5M Buy
123,121
+3,786
+3% +$311K 0.2% 83
2017
Q2
$9.82M Buy
119,335
+3,808
+3% +$311K 0.2% 81
2017
Q1
$9.72M Buy
115,527
+5,480
+5% +$439K 0.21% 75
2016
Q4
$8.09M Buy
110,047
+4,412
+4% +$329K 0.19% 79
2016
Q3
$8.48M Sell
105,635
-1,687
-2% -$135K 0.2% 71
2016
Q2
$8.45M Sell
107,322
-1,382
-1% -$104K 0.21% 72
2016
Q1
$7.83M Sell
108,704
-5,886
-5% -$445K 0.19% 79
2015
Q4
$9.65M Sell
114,590
-21,895
-16% -$1.82M 0.24% 66
2015
Q3
$11.4M Buy
136,485
+514
+0.4% +$43.4K 0.3% 49
2015
Q2
$11.4M Sell
135,971
-2,541
-2% -$194K 0.29% 52
2015
Q1
$10.1M Sell
138,512
-1,113
-0.8% -$79.2K 0.24% 60
2014
Q4
$9.63M Buy
139,625
+18,383
+15% +$1.24M 0.24% 57
2014
Q3
$7.86M Buy
121,242
+2,609
+2% +$165K 0.22% 57
2014
Q2
$7.38M Buy
118,633
+2,480
+2% +$148K 0.22% 54
2014
Q1
$6.84M Buy
116,153
+3,021
+3% +$169K 0.19% 62
2013
Q4
$5.77M Sell
113,132
-10,395
-8% -$521K 0.16% 68
2013
Q3
$6.22M Buy
123,527
+3,127
+3% +$164K 0.18% 63
2013
Q2
$5.91M Buy
+120,400
New +$6.55M 0.18% 57

Other funds holding LLY

Norinchukin Bank's LLY Position: Q1 2026 in Review

Norinchukin Bank reduced its Eli Lilly (LLY) stake by 0.13% in Q1 2026, selling an estimated $62.9K and leaving 47,144 shares worth $43.4M. The position accounts for 0.51% of the portfolio, ranked #31.

Norinchukin Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $50.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Norinchukin Bank held 47,144 shares of Eli Lilly worth $43.4M as of Q1 2026.
  • Norinchukin Bank sold 62 Eli Lilly shares in Q1 2026, an estimated $62.9K.
  • Eli Lilly made up 0.51% of Norinchukin Bank's portfolio in Q1 2026, its #31 holding.
  • Norinchukin Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Norinchukin Bank's Eli Lilly position peaked at $50.7M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.